NICOLE MCCLAVY: Open Payments
NPI 1053963900 · PERRY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 71 payments from 16 companies in 2025. Trend: 2023 $781 · 2024 $1,490 · 2025 $1,411
Food & beverage: $1,300Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $264 |
| Otsuka America Pharmaceutical, Inc. | 12 | $224 |
| Teva Pharmaceuticals USA, Inc. | 6 | $199 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $189 |
| Vanda Pharmaceuticals Inc. | 7 | $146 |
| Lundbeck LLC | 8 | $143 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| Alkermes, Inc. | 2 | $43 |
| PFIZER INC. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: REXULTI, VRAYLAR, CAPLYTA, FANAPT, UZEDY, COBENFY, ARISTADA, ABILIFY MAINTENA.
Industry payments across IA — which companies pay providers there.
